Medesis Pharma SA
PAR:ALMDP
Medesis Pharma SA
PAR:ALMDP
Price:
0.35
EUR
Market Cap:
€1.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medesis Pharma SA
PAR:ALMDP
|
FR |
|
K
|
Kent Industrial Co Ltd
TWSE:6606
|
TW |
|
Aygaz AS
IST:AYGAZ.E
|
TR |
|
Kanoria Chemicals and Industries Ltd
NSE:KANORICHEM
|
IN |
|
P
|
Pne Pcb Bhd
KLSE:PNEPCB
|
MY |
|
Victoria Gold Corp
TSX:VGCX
|
CA |
Balance Sheet
Balance Sheet Decomposition
Medesis Pharma SA
Medesis Pharma SA
Balance Sheet Decomposition is not available for
Medesis Pharma SA
Medesis Pharma SA
Balance Sheet
Medesis Pharma SA
Medesis Pharma SA
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
3
|
|
| Cash Equivalents |
0
|
0
|
0
|
3
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-56%
|
1
+17%
|
4
+416%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
2
|
2
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
|
| Total Liabilities |
3
N/A
|
3
+25%
|
3
-7%
|
3
-8%
|
|
| Equity | |||||
| Common Stock |
6
|
6
|
7
|
9
|
|
| Retained Earnings |
16
|
18
|
19
|
22
|
|
| Additional Paid In Capital |
10
|
10
|
10
|
15
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
-176%
|
2
+14%
|
2
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-56%
|
1
+17%
|
4
+416%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
